Financing
Proceeds from (repayments of) short-term borrowings, net
Boston Scientific Proceeds from (repayments of) short-term borrowings, net increased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 100.0%, from -$192.00M to $0.00.
Analysis
StatementCash Flow Statement
SectionFinancing
CategoryLeverage
SignalContext dependent
VolatilityModerate
First reportedQ1 2015
Last reportedQ1 2026May 1, 2026
How to read this metric
Higher net proceeds suggest increased reliance on short-term debt for liquidity, while net repayments indicate deleveraging or sufficient internal cash flow.
Detailed definition
Reflects the net cash flow generated from the issuance or repayment of commercial paper, which are short-term, unsecured...
Peer comparison
Standard for large enterprises with active treasury departments; comparable to short-term debt issuance metrics at peer firms.
Metric ID:
financing_proceeds_from_repayments_of_commercial_paperHistorical Data
15 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $223.00M | -$155.00M | $0.00 | $37.00M | -$41.00M | $0.00 | $0.00 | $0.00 | $0.00 | $187.00M | -$192.00M | $0.00 |
| QoQ Change | — | — | — | — | -169.5% | +100.0% | — | -210.8% | +100.0% | — | — | — | — | -202.7% | +100.0% |
| YoY Change | — | — | — | — | — | -100.0% | — | +73.5% | — | — | -100.0% | +100.0% | — | — | +100.0% |
Range-$192.00M – $223.00M
Avg YoY Growth+14.7%
Median YoY Growth+73.5%
Proceeds from (repayments of) short-term borrowings, net at Other Companies
Frequently Asked Questions
- What is Boston Scientific's proceeds from (repayments of) short-term borrowings, net?
- Boston Scientific (BSX) reported proceeds from (repayments of) short-term borrowings, net of $0.00 in Q1 2026.
- How has Boston Scientific's proceeds from (repayments of) short-term borrowings, net changed year-over-year?
- Boston Scientific's proceeds from (repayments of) short-term borrowings, net increased by 100.0% year-over-year, from -$192.00M to $0.00.
- What does proceeds from (repayments of) short-term borrowings, net mean?
- The net cash change resulting from borrowing or repaying short-term debt via commercial paper.